BiondVax publishes investor presentation on May 4, 2023; no financial results disclosed

Scinai Immunotherapeutics Ltd.

Presentation made available on company website and discussed in meetings starting May 4, 2023.
Forward-looking statements reference NanoAbs pipeline, manufacturing facility, and potential collaborations.
No new financial guidance, earnings, or material operational updates were provided in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.